MedPath

Islet Function and Clinical Analyses of Transplant Recipients

Terminated
Conditions
Type One Diabetes Mellitus
Interventions
Other: OGTT (Oral Glucose Tolerance Test)
Registration Number
NCT00870831
Lead Sponsor
Washington University School of Medicine
Brief Summary

To follow the patterns and natural history of Islet Transplant recipients (the ones that were involved in the Modified Edmonton Protocol) using oral glucose to check sugar levels as well as insulin and C-peptide over the course of 5 years

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Type 1 Diabetes with hypoglycemia unawareness that received a Islet Transplant here at Washington University
  • "control" subjects were matched to the transplant recipients base upon age, height, weight, & race (and could not have diabetes)
Exclusion Criteria
  • well controlled Type 1 diabetes
  • transplant failure
  • unable to match potential subject to a recipient

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Islet RecipientOGTT (Oral Glucose Tolerance Test)Subjects that have successfully received and maintained an Islet transplant at Washington University Center for Islet Transplantation
ControlOGTT (Oral Glucose Tolerance Test)subjects that were similar in height, weight and age that did NOT have diabetes to act as the comparative group
Primary Outcome Measures
NameTimeMethod
OGTT will be performed every 6 months for 5 years in subjects with a functioning Islet Transplant5 years
Secondary Outcome Measures
NameTimeMethod
The OGTT reflects the function of the Islet transplant and could be used as an indication of Islet Transplant function5yrs
© Copyright 2025. All Rights Reserved by MedPath